Due to the relevant biological role of CK2 in CLL pathogenesis [26, 27, 29, 39–43], we sought to investigate whether CK2 is involved in modulating USP7 activity in this disease. The gene discussed is USP7; the disease is B-cell chronic lymphocytic leukemia.